Nationwide Fund Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,032,650
Closed -$83.7M 826
2017
Q3
$83.7M Sell
1,032,650
-98,833
-9% -$7.56M 0.33% 36
2017
Q2
$80.1M Sell
1,131,483
-16,254
-1% -$1.08M 0.32% 35
2017
Q1
$78M Sell
1,147,737
-98,781
-8% -$6.95M 0.31% 35
2016
Q4
$89.3M Sell
1,246,518
-111,177
-8% -$8.26M 0.37% 28
2016
Q3
$107M Sell
1,357,695
-28,595
-2% -$2.32M 0.45% 25
2016
Q2
$116M Sell
1,386,290
-190,492
-12% -$16.9M 0.5% 23
2016
Q1
$145M Sell
1,576,782
-32,736
-2% -$2.95M 0.63% 15
2015
Q4
$163M Buy
1,609,518
+255,845
+19% +$26.6M 0.7% 10
2015
Q3
$133M Buy
1,353,673
+23,320
+2% +$2.59M 0.6% 15
2015
Q2
$156M Buy
1,330,353
+149,719
+13% +$16.4M 0.64% 10
2015
Q1
$116M Sell
1,180,634
-356,739
-23% -$36.2M 0.47% 23
2014
Q4
$145M Buy
1,537,373
+176,556
+13% +$18.3M 0.62% 9
2014
Q3
$145M Sell
1,360,817
-57,640
-4% -$5.64M 0.61% 11
2014
Q2
$118M Sell
1,418,457
-233,681
-14% -$18.2M 0.48% 17
2014
Q1
$117M Sell
1,652,138
-95,429
-5% -$7.48M 0.54% 16
2013
Q4
$131M Sell
1,747,567
-33,525
-2% -$2.33M 0.55% 14
2013
Q3
$112M Sell
1,781,092
-126,027
-7% -$7.53M 0.5% 18
2013
Q2
$97.7M Buy
+1,907,119
New +$99.4M 0.51% 23

Other funds holding GILD

Nationwide Fund Advisors's GILD Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 1,032,650 shares — an estimated $83.7M sold.

Nationwide Fund Advisors first reported a position in GILD in Q2 2013 and held it in 18 quarters. The position peaked at $163M in Q4 2015. 1,575 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 1,032,650 Gilead Sciences shares in Q4 2017, an estimated $83.7M.
  • Nationwide Fund Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Gilead Sciences position peaked at $163M in Q4 2015.
  • 1,575 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.